Leprosy Mailing List – November 30, 2015
Ref.: (LML) Draft WHO Leprosy Strategy 2016-2020
From: Pranab Kumar Das, Birmingham, UK
Dear Pieter,
This letter is in reference to Dr Shetty's communication on 25th November 2015 concerning on the application of U-MDT vs R-MDT. It seems that the cardinal debate has been long surrounding relapse, progressive silent nerve damage, re-infection and reactions etc. sounding the disease almost "mission impossible" in terms of continuous transmission and unpreventable episodic reactions. All of the world famous leprosy experts seem to go round and round these cardinal problems.
Following all these arguments, my naive conclusion is that U-MDT may be a rational alternative in a mass programme and indeed that needs to be superimposed with timely examination of NFI, symptoms of reactions and the expert management, that are suitable for mass programme. I wonder whether such strategy is being adopted anywhere probably in Brazil.
Personally, I feel that declining knowledge in clinical expertise in leprosy needs to be revitalised in Medical curricula.
Regards,
Pran
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
 | This email has been sent from a virus-free computer protected by Avast. www.avast.com |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.